Cyclophosphamide J Code: J9070

Drug & Product Overview

HCPCS Descriptor Cyclophosphamide, 100 mg

HCPCS Added Date January 1, 1984

Manufacturer Multiple Manufacturers

Route of Administration Intravenous, Oral

Generic Status HCPCS Discontinued

Dosage Type Single-Dose, Multi-Dose

Dosage Form Injection, Powder, For Solution | Injection, Powder, Lyophilized, For Solution | Injection, Solution | Not Available

About Cyclophosphamide

Cyclophosphamide is a medication aligned to the HCPCS J Code: J9070 for billing, pricing, and reimbursement purposes in the United States. It is an Oncology drug administered via the intravenous or oral routes and manufactured by multiple companies.

Manufacturers, reach out to us to add more information.

NDC Code Information

41 NDC packages are crosswalked to J9070. Package detail is available to logged-in subscribers.

NDC Code	Drug	Manufacturer	Billing Units / Pkg	Package Size
•••••-••••-•• Log in to view	Cyclophosphamide
	Cyclophosphamide
	Cyclophosphamide
	Cyclophosphamide

Login to view 41 NDC packages View pricing, complete NDC-to-HCPCS alignments, and package details.

Login →

Cyclophosphamide CPT Administration Codes

CPT Code	Description
96409	Chemotherapy administration; intravenous, push technique, single or initial substance/drug
96413	Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug
96415 Login for More	Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure) Login for More

Not on the CMS JW / JZ list

CMS does not include Cyclophosphamide (J9070) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing J9070. Wastage billing guide →

Cyclophosphamide Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

Malignant Diseases Malignant Diseases (malignant lymphomas, Hodgkin's disease, multiple myeloma, leukemias, mycosis fungoides, neuroblastoma, adenocarcinoma of the ovary, retinoblastoma, carcinoma of the breast) Malignant Diseases (malignant lymphomas, multiple myeloma, leukemias, mycosis fungoides, neuroblastoma, adenocarcinoma of the ovary, retinoblastoma, carcinoma of the breast) Malignant lymphomas (Stages III and IV Ann Arbor), Hodgkin's disease, lymphocytic lymphoma, mixed-cell type lymphoma, histiocytic lymphoma, Burkitt's lymphoma; multiple myeloma; leukemias (chronic lymphocytic leukemia, chronic granulocytic leukemia, acute myelogenous and monocytic leukemia, acute lymphoblastic (stem-cell) leukemia); mycosis fungoides; neuroblastoma; adenocarcinoma of the ovary; retinoblastoma; carcinoma of the breast Malignant lymphomas, multiple myeloma, leukemias, mycosis fungoides, neuroblastoma, adenocarcinoma of the ovary, retinoblastoma, carcinoma of the breast Minimal Change Nephrotic Syndrome Minimal change nephrotic syndrome

Frequently Asked Questions

Is there an available Cyclophosphamide billing and coding guide?

We have not yet identified a manufacturer source of Cyclophosphamide billing and coding information.

Are there any available Cyclophosphamide patient assistance programs?

Our team did not identify a source for Cyclophosphamide patient assistance information. Please reach out to our team if you feel that this is a mistake.

Where can I find Cyclophosphamide prescribing information?

Cyclophosphamide prescribing information can be found at the link below: Visit Here →

Where can I find Cyclophosphamide side effect information?

Information regarding Cyclophosphamide's side effects can be found at MedlinePlus Visit Here →

Does billing Cyclophosphamide require JZ/JW wastage modifiers?

CMS does not include Cyclophosphamide (J9070) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing J9070. For more information, visit the link below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.